Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$981M |
| 2 |
Apple
AAPL
|
+$704M |
| 3 |
Amazon
AMZN
|
+$670M |
| 4 |
Merck
MRK
|
+$431M |
| 5 |
NVIDIA
NVDA
|
+$414M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KSU
Kansas City Southern
KSU
|
+$441M |
| 2 |
JD.com
JD
|
+$196M |
| 3 |
Aon
AON
|
+$184M |
| 4 |
VER
VEREIT, Inc.
VER
|
+$165M |
| 5 |
Dell
DELL
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.2% |
| 2 | Healthcare | 13.25% |
| 3 | Financials | 13.01% |
| 4 | Consumer Discretionary | 11.99% |
| 5 | Communication Services | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AXDX
3176
DELISTED
Accelerate Diagnostics
AXDX
| $2.94M | ﹤0.01% |
56,247
+2,213
| +4% | +$123K |
|
|
MILE
3177
DELISTED
Metromile, Inc. Common Stock
MILE
| $2.94M | ﹤0.01% |
1,340,969
-170,469
| -11% | -$486K |
|
|
FRBK
3178
DELISTED
Republic First Bancorp Inc
FRBK
| $2.93M | ﹤0.01% |
788,158
+18,583
| +2% | +$62.4K |
|
3179
authID Inc
AUID
$13.2M
| $2.93M | ﹤0.01% |
26,098
+24,520
| +1,554% | +$2.87M |
|
3180
CorMedix
CRMD
$590M
| $2.93M | ﹤0.01% |
643,458
-27,545
| -4% | -$137K |
|
3181
Q32 Bio
QTTB
$480M
| $2.92M | ﹤0.01% |
44,633
+4,744
| +12% | +$460K |
|
3182
Vor Biopharma
VOR
$1.21B
| $2.91M | ﹤0.01% |
12,539
-1,058
| -8% | -$305K |
|
|
TCDA
3183
DELISTED
Tricida, Inc. Common Stock
TCDA
| $2.91M | ﹤0.01% |
304,654
+19,890
| +7% | +$128K |
|
3184
Velocity Financial
VEL
$700M
| $2.91M | ﹤0.01% |
212,413
+70,741
| +50% | +$912K |
|
3185
Farmers & Merchants Bancorp
FMAO
$479M
| $2.91M | ﹤0.01% |
88,598
+1,247
| +1% | +$34K |
|
3186
Cytosorbents Corp
CTSO
$23.7M
| $2.91M | ﹤0.01% |
693,915
-3,250
| -0.5% | -$18.2K |
|
3187
Tyra Biosciences
TYRA
$1.93B
| $2.9M | ﹤0.01% |
+206,381
| New | +$4.1M |
|
|
TCRR
3188
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $2.9M | ﹤0.01% |
621,452
+167,119
| +37% | +$1.04M |
|
3189
AbCellera Biologics
ABCL
$1.86B
| $2.89M | ﹤0.01% |
201,868
+170,204
| +538% | +$2.58M |
|
3190
Newegg Commerce
NEGG
$321M
| $2.88M | ﹤0.01% |
13,914
+30
| +0.2% | +$8.48K |
|
|
GOCO
3191
DELISTED
GoHealth
GOCO
| $2.87M | ﹤0.01% |
50,466
+8,996
| +22% | +$600K |
|
3192
SandRidge Energy
SD
$500M
| $2.86M | ﹤0.01% |
273,359
+4,960
| +2% | +$58.9K |
|
3193
BARK
BARK
$89.6M
| $2.84M | ﹤0.01% |
33,708
-38
| -0.1% | -$4.35K |
|
|
CDAK
3194
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
| $2.83M | ﹤0.01% |
254,534
+24,593
| +11% | +$341K |
|
3195
Neurogene
NGNE
$686M
| $2.83M | ﹤0.01% |
29,407
-1,484
| -5% | -$181K |
|
|
LTRPA
3196
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $2.83M | ﹤0.01% |
1,305,509
+172,018
| +15% | +$486K |
|
3197
Tarsus Pharmaceuticals
TARS
$2.67B
| $2.83M | ﹤0.01% |
125,815
+2,117
| +2% | +$55K |
|
|
VOXX
3198
DELISTED
VOXX International Corporation Class A
VOXX
| $2.83M | ﹤0.01% |
277,904
-23,666
| -8% | -$263K |
|
3199
Nathan's Famous
NATH
$402M
| $2.82M | ﹤0.01% |
48,267
-445
| -0.9% | -$27.2K |
|
|
AKYA
3200
DELISTED
Akoya BioSciences
AKYA
| $2.81M | ﹤0.01% |
183,215
+49,443
| +37% | +$647K |
|
Similar funds
Geode Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, Geode Capital Management held 5,071 positions worth $830B, up 12% from $743B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Geode Capital Management's Q4 2021 filing shows 216 new, 2,976 increased, 1,070 reduced and 95 closed positions. Its largest new stake was Rivian: 2,078,098 shares worth $215M. The largest sale was Kansas City Southern, an estimated $441M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q4 2021 buy was Rivian: 2,078,098 shares worth $215M.
- Geode Capital Management added most to Microsoft in Q4 2021, an estimated $981M increase.
- Geode Capital Management's biggest Q4 2021 reduction was JD.com, cutting an estimated $196M.
- Geode Capital Management fully exited Kansas City Southern in Q4 2021, selling an estimated $441M.
- Geode Capital Management's ten largest holdings make up 24% of its $830B portfolio in Q4 2021.
- Geode Capital Management opened 216 new positions and closed 95 in Q4 2021.
- Geode Capital Management's portfolio value rose 12% quarter-over-quarter to $830B.
Based on Geode Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.